http://ir.regulusrx.com/news-releases/news-release-details/regulus-present-cowen-and-company-38th-annual-health-care
LA JOLLA, Calif., March 5, 2018 /PRNewswire/ -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present a company overview at the Cowen and Company 38th Annual Health Care Conference in Boston on Monday, March 12, 2018 at 1:30pm Eastern Time.
A live webcast of the presentation can be accessed on the Investors page of the Regulus website at
www.regulusrx.com. An archived replay of the webcast will be available on the Company's website after the conference.